Vascular homing peptides with cell-penetrating properties

Area of Science:

• Molecular biology
• Vascular biology
• Oncology

Background:

• In vivo screening of phage-displayed peptide libraries reveals molecular heterogeneity in normal tissue vasculature.
• Pathological lesions, particularly tumors, exhibit distinct vascular signatures compared to normal tissues.
• Tumor vasculature molecular changes correlate with tumor progression, differentiating premalignant from malignant lesions.

Purpose of the Study:

• To characterize the molecular differences in tumor vasculature compared to normal vasculature.
• To identify cell-type-specific peptides that home to tumor vasculature and penetrate tumor cells.
• To explore the potential of these peptides in targeted drug delivery for cancer therapy.

Main Methods:

• In vivo screening of phage-displayed peptide libraries.
• Analysis of molecular signatures in blood and lymphatic vessels of normal tissues, premalignant lesions, and tumors.
• Evaluation of tumor-homing and cell-penetrating capabilities of identified peptides.

Main Results:

• Tumor blood and lymphatic vessels display distinct molecular profiles compared to normal vessels.
• Molecular vascular alterations parallel tumor development stages.
• Identified tumor-homing peptides exhibit cell-type specificity, penetrating tumor endothelial and tumor cells but not normal cells.
• These peptides can be directed to experimental tumors.

Conclusions:

• Tumor vasculature possesses unique molecular signatures that change with tumor progression.
• Cell-penetrating peptides targeting tumor vasculature offer a promising strategy for cancer therapy.
• These peptides can deliver therapeutic agents specifically into tumor cells, potentially to subcellular organelles like the nucleus.